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NMDAR-dependent Argonaute 2 phosphorylation
regulates miRNA activity and dendritic
spine plasticity
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Abstract
MicroRNAs (miRNAs) repress translation of target mRNAs by asso-
ciating with Argonaute (Ago) proteins to form the RNA-induced
silencing complex (RISC), underpinning a powerful mechanism for
fine-tuning protein expression. Specific miRNAs are required for
NMDA receptor (NMDAR)-dependent synaptic plasticity by modu-
lating the translation of proteins involved in dendritic spine
morphogenesis or synaptic transmission. However, it is unknown
how NMDAR stimulation stimulates RISC activity to rapidly repress
translation of synaptic proteins. We show that NMDAR stimulation
transiently increases Akt-dependent phosphorylation of Ago2 at
S387, which causes an increase in binding to GW182 and a rapid
increase in translational repression of LIMK1 via miR-134. Further-
more, NMDAR-dependent down-regulation of endogenous LIMK1
translation in dendrites and dendritic spine shrinkage requires
phospho-regulation of Ago2 at S387. AMPAR trafficking and
hippocampal LTD do not involve S387 phosphorylation, defining
this mechanism as a specific pathway for structural plasticity. This
work defines a novel mechanism for the rapid transduction of
NMDAR stimulation into miRNA-mediated translational repression
to control dendritic spine morphology.
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Introduction
MicroRNAs (miRNAs) are small non-coding endogenous RNA mole-
cules that repress the translation of target mRNAs through comple-
mentary binding in the transcript 30-untranslated region (30UTR), a
process that has emerged in the past decade as being fundamentally
important for fine-tuning protein synthesis in a wide range of cellu-
lar processes. Nearly half of all mammalian miRNAs are expressed
at high levels in the brain, where they regulate neuronal develop-
ment, spine morphogenesis, and synaptic function (Kosik, 2006;
McNeill & Van Vactor, 2012; Weiss et al, 2015; Hu & Li, 2017). A
number of miRNAs have been shown to be involved in specific
forms of learning and memory, and dysfunction of miRNA systems
is implicated in neurological and neuropsychiatric diseases includ-
ing Alzheimer’s, Huntington’s, schizophrenia and drug addiction
(Wang et al, 2012; Kocerha et al, 2015). Furthermore, a large
proportion of neuronal miRNAs are enriched in dendrites, and
several have been assigned roles in modulating the local translation
of specific proteins involved in excitatory synaptic transmission or
in regulating the actin cytoskeleton to control the morphology of
dendritic spines, which house excitatory synapses (Lippi et al, 2011;
Bicker et al, 2014; Hu et al, 2014, 2015; Gu et al, 2015).
The size and morphology of dendritic spines are dynamically
regulated. Structural plasticity of spines occurs alongside plasticity
of synaptic transmission, requires modifications to the underlying
actin cytoskeleton and is regulated by specific kinds of synaptic
activity, most notably NMDA receptor (NMDAR) stimulation (Kasai
et al, 2010; Bosch & Hayashi, 2012; Fortin et al, 2012). Long-term
potentiation (LTP) is an increase in synaptic strength caused by up-
regulating synaptic AMPA receptors (AMPARs) and involves an
increase in spine size, whereas long-term depression (LTD) is a
decrease in synaptic strength caused by the internalisation of synap-
tic AMPARs and associated spine shrinkage (Hanley, 2008; Anggono
& Huganir, 2012; Fortin et al, 2012). Long-term plasticity of
dendritic spines is thought to be an important cellular mechanism
for information storage in the brain and therefore to play an essen-
tial role in learning and memory and the fine-tuning of neural
circuitry during development (Kasai et al, 2010; Caroni et al, 2012).
Long-term changes in synaptic efficacy that underlie the persis-
tent formation of memories require changes in the synthesis of
synaptic proteins by the activity-dependent local regulation of
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mRNA translation in dendrites close to synapses (Bramham &
Wells, 2007), and a role for miRNAs in this process is emerging
(Weiss et al, 2015). However, it is unclear how plasticity stimuli
such as NMDAR stimulation are transduced into changes in miRNA
activity. While the expression levels of specific miRNAs are
increased in response to the induction of NMDAR-dependent chemi-
cal LTD (cLTD), it has been shown that their gene silencing activi-
ties are required for dendritic spine shrinkage or AMPAR trafficking
before a detectable increase in the expression of miRNA (Hu et al,
2014, 2015). Therefore, the increase in expression levels of these
miRNAs is not fast enough to mediate modulation of the local
proteome to drive the miRNA-dependent changes in AMPAR func-
tion or spine morphology that take place soon after stimulation.
Mechanisms for the rapid modulation of miRNA-dependent gene
silencing in response to the induction of synaptic or structural plas-
ticity represent a critical gap in our understanding of how protein
translation is regulated in dendrites.
Argonaute (Ago) proteins are essential for miRNA-mediated gene
silencing (Meister, 2013; Wilson & Doudna, 2013). MiRNAs associ-
ate with Agos in RNA-induced silencing complexes (RISCs) and
guide them to target mRNAs through complementary base pairing
to promote mRNA degradation or translational repression (Meister,
2013; Iwakawa & Tomari, 2015). Agos interact with numerous
proteins that are essential for or modulate their gene silencing activ-
ity. In particular, GW182 (also known as TNRC6A) is an evolution-
arily conserved component of RISCs and is essential for mediating
the gene silencing steps downstream of RISC formation by recruiting
additional proteins with relevant scaffolding or enzymatic activities
(Pfaff & Meister, 2013; Jonas & Izaurralde, 2015). Importantly, Ago2
can be phosphorylated at a number of residues, some of which have
been suggested to regulate RISC activity in non-neuronal cell lines
by controlling Ago2-RNA or Ago2-protein interactions (Jee & Lai,
2014). Phosphorylation of Ago2 at serine 387 (S387) enhances its
interaction with GW182 and increases miRNA-mediated transla-
tional repression in HeLa cells (Horman et al, 2013). The regulation
of RISC protein–protein interactions or RISC activity by Ago2 phos-
phorylation remains completely unexplored in neurons, and we
hypothesised that regulating critical RISC protein–protein interac-
tions via Ago2 phosphorylation is a key mechanism to mediate the
rapid modulation of miRNA-mediated gene silencing in dendrites in
response to neuronal stimulation.
Here, we show that NMDAR stimulation causes an increase in
phosphorylation of Ago2 at S387 by Akt, which increases Ago2
interactions with GW182 and DDX6. Phospho-regulation of Ago2 at
S387 rapidly modulates translational repression of Lim kinase 1
(LIMK1) via miR-134 and is required for NMDAR-dependent
dendritic spine shrinkage, but not AMPAR trafficking.
Results
Interaction between Ago2 and GW182 is enhanced by
NMDAR stimulation
To investigate the regulation of RISC in response to NMDAR stim-
ulation, we focussed on the interaction between Ago2 and GW182,
because this interaction is a critical regulator of RISC function
(Pfaff & Meister, 2013; Jonas & Izaurralde, 2015). Co-immunopreci-
pitation of endogenous GW182 with endogenous Ago2 from
cultured cortical neurons was significantly increased 10 min after
bath application of NMDA (Fig 1A). We also analysed the associa-
tion of Ago2 with the RNA helicase DDX6, which associates with
Ago2 via GW182, and MOV10, which is recruited to RISC by an
unknown mechanism (Meister et al, 2005; Chen et al, 2014).
While Ago2-DDX6 interactions were significantly increased by
NMDAR stimulation, binding to MOV10 was unaffected (Fig 1A).
Ago1 interactions with GW182 and with DDx6 were unaffected by
NMDAR stimulation (Fig EV1). Consistent with an increase in
physical association between the two proteins, co-localisation of
endogenous Ago2 and GW182 in neuronal dendrites analysed by
immunocytochemistry was significantly increased by NMDAR stim-
ulation (Fig 1B–D). Basal Ago2-GW182 co-localisation was more
pronounced in the cell body compared to dendrites; however, no
significant changes in the cell body were observed after NMDAR
stimulation (Fig 1B and E).
Akt-mediated phosphorylation of Ago2 at S387 is required for the
NMDA-induced increase in Ago2-GW182 interaction
Previous reports suggest the Ago2-GW182 interaction is regulated in
HeLa cells by phosphorylation of Ago2 at S387 by the kinase Akt
(Horman et al, 2013; Bridge et al, 2017). We therefore hypothesised
that the NMDAR-stimulated increase in binding would be mediated
by a similar mechanism. To test this hypothesis, we investigated the
effect of the specific Akt inhibitor Akti-1/2 on the Ago2-GW182
interaction. We also tested inhibitors of PKC (chelerythrine) and
GSK3b (CT99021), which are kinases implicated in LTD expression
(Seidenman et al, 2003; Peineau et al, 2007). The Akt inhibitor
▸Figure 1. Ago2 association with GW182 in neuronal dendrites increases in response to NMDAR stimulation.A Endogenous Ago2-GW182 and Ago2-DDX6 interactions increase in response to NMDAR stimulation. Cortical neuronal cultures were exposed to NMDA or vehicle for
3 min, and lysates were prepared 10 min after NMDA washout and immunoprecipitated with Ago2 antibodies. Proteins were detected by Western blotting. Graph
shows quantification of Ago2-GW182 interaction, normalised to vehicle control; n = 5. *P < 0.05; ***P < 0.001; t-test; mean  SEM.
B Analysis of endogenous Ago2-GW182 co-localisation in cortical neuronal cultures. Cortical neuronal cultures were exposed to NMDA or vehicle for 3 min, fixed 10 min
after NMDA washout, permeabilised and co-stained with Ago2 and GW182 antibodies. Representative whole-cell images are shown. Scale bar = 50 lm.
C Endogenous GW182-Ago2 co-localisation increases in response to NMDAR stimulation in neuronal dendrites. Images show dendrites taken from boxed region in (B),
above. Graph shows Pearson’s co-localisation coefficients; n = 4 independent experiments (18–24 cells per condition). *P < 0.05, t-test. Scale bar = 10 lm.
Mean  SEM.
D Line-scan analyses of Ago2 and GW182 fluorescence intensities in control and NMDA-stimulated dendrites shown in (C).
E NMDAR stimulation has no effect on endogenous Ago2-GW182 co-localisation in neuronal cell bodies. Images show cell bodies taken from boxed region in (B). Graph
shows Pearson’s co-localisation coefficients; n = 4 independent experiments (18–20 cells per condition), t-test. Scale bar = 10 lm. Mean  SEM.
Source data are available online for this figure.
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Akti-1/2 completely blocked the NMDA-induced increase in Ago2-
GW182 binding, while chelerythrine and CT99021 had no effect
(Fig 2A). Next, we analysed Ago2 phosphorylation at S387 using a
phospho-specific antibody. NMDAR activation caused a significant
increase in S387 phosphorylation, which was blocked by Akti-1/2,
but not by chelerythrine or CT99021 (Fig 2B). Interestingly, Akt
inhibition reduced Ago2 phosphorylation and Ago2-GW182 interac-
tion under unstimulated conditions, suggesting that Akt is basally
active to phosphorylate S387 and promote GW182 binding to Ago2
(Fig 2A and B). These results strongly suggest that Ago2 phosphory-
lation and the increase in GW182-Ago2 interaction are caused by
NMDAR-dependent Akt activation. To provide further support for
this mechanism, we tested the effect of a second Akt inhibitor,
KP372-1 and also an Akt activator, sc79. KP372-1 had a similar
effect as Akti-1/2, blocking both the NMDAR-stimulated increase in
Ago2 phosphorylation at S387, and the increase in Ago2-GW182
binding (Fig 2C and D). In contrast, sc79 caused an increase in S387
phosphorylation and Ago2-GW182 interaction under basal condi-
tions, which occluded the effect of NMDA (Fig 2C and D). The p38
MAPK pathway has also been shown to phosphorylate Ago2 at
S387 in non-neuronal cell lines (Zeng et al, 2008), so we analysed
Ago2-GW182 binding and S387 phosphorylation in the presence of
the p38 MAPK inhibitor SB203580. In contrast to Akti-1/2,
SB203580 did not affect the NMDAR-dependent increase in GW182
binding or S387 phosphorylation (Fig 2E and F). Taken together,
these results demonstrate that phosphorylation of Ago2 at S387 and
Ago2 binding to GW182 are increased by NMDAR stimulation in an
Akt-dependent manner.
To test directly whether the NMDAR-dependent increase in
Ago2-GW182 binding is caused by Ago2 phosphorylation at
S387, we generated molecular replacement constructs that
express Ago2 shRNA as well as GFP or GFP-tagged shRNA-resis-
tant Ago2. In addition to wild-type (WT) Ago2, we made
constructs to express a phospho-null (S387A) or a phospho-
mimic (S387D) mutant, hypothesising that the S387A mutant
would behave in a similar manner as dephosphorylated Ago2,
while S387D would show similar properties as phosphorylated
Ago2. Appendix Fig S1 shows that the Ago2 shRNA efficiently
knocked down endogenous Ago2 to ~ 23% of control levels. Co-
expression of shRNA-resistant GFP-WT, GFP-S387A or GFP-
S387D resulted in a slight over-rescue of Ago2 expression, which
was ~ 30% higher than endogenous Ago2 under control condi-
tions, and all three recombinant proteins were expressed at the
same level (Appendix Fig S1). To investigate the effect of S387
phosphorylation mutants on GW182 binding, we performed GFP-
trap pull-downs on lysates prepared from cortical neurons trans-
fected with control or molecular replacement constructs, and
analysed endogenous GW182 binding to GFP-WT-Ago2, GFP-
S387A-Ago2 and GFP-S387D-Ago2. Under unstimulated condi-
tions, GFP-S387D-Ago2 showed a dramatic increase in binding to
endogenous GW182 compared to GFP-WT-Ago2, while GFP-
S387A-Ago2 bound GW182 slightly less than WT, which did not
reach statistical significance (Fig 3A). While NMDAR stimulation
caused a similar increase in GW182 binding to GFP-WT-Ago2
compared to endogenous Ago2, NMDA had no effect on GW182
binding to either GFP-S387A-Ago2 or GFP-S387D-Ago2. Hence,
the S387A mutation blocks the effect of NMDAR stimulation,
whereas S387D mimics and occludes the effect of NMDA. All
three mammalian GW182 isoforms (TNRC6A-C) showed similar
patterns of binding to Ago2 S387 mutants in heterologous cells,
suggesting that the binding of Ago2 to all three isoforms is
subject to regulation by phosphorylation at S387 (Fig EV2). We
also analysed the interactions between GFP-Ago2 and endoge-
nous MOV10 and DDX6 in neurons. While the interaction
between Ago2 and MOV10 was unaffected by S387 mutations,
association with DDX6 showed a similar pattern as GW182 bind-
ing (Fig 3A). We previously described an interaction between
Ago2 and the BAR domain protein PICK1, which dissociates in
response to NMDAR stimulation (Antoniou et al, 2014; Rajgor
et al, 2017). This interaction was unaffected by S387 mutations
in Ago2 (Fig 3A). Furthermore, NMDAR-dependent Ago2 phos-
phorylation at S387 was unaffected by molecular replacement of
PICK1 with GFP-PICK1-AX10, a mutant whose interaction with
Ago2 is resistant to NMDAR stimulation (Rajgor et al, 2017;
▸Figure 2. NMDAR-dependent increase in Ago2-GW182 interaction and Ago2 phosphorylation at S387 requires Akt activity.A NMDAR-stimulated increase in Ago2-GW182 interaction is Akt-dependent. Cortical neuronal cultures were treated with Akti-1/2 (Akt inhibitor), chelerythrine (Chel,
PKC inhibitor) or CT99021 (GSK-3b inhibitor) 20 min before NMDA or vehicle application. Lysates were prepared 10 min after NMDA washout and
immunoprecipitated with Ago2 antibodies or control IgG as shown. Proteins were detected by Western blotting. The inputs are shown in (B). Graph shows
quantification of Ago2-GW182 interaction, normalised to vehicle control; n = 3.
B NMDAR-stimulated increase in Ago2 phosphorylation at S387 is Akt-dependent. The same lysates from (A) (1% of input) were analysed by Western blotting using
antibodies against pS387 Ago2, Ago2, GW182 and GAPDH as a loading control. Graph shows quantification of pS387 Ago2 levels normalised to total Ago2; n = 3.
C Further evidence that the NMDAR-stimulated increase in Ago2-GW182 interaction is Akt-dependent. Cortical neuronal cultures were treated with Akti-1/2, KP372-1
(Akt inhibitor) or sc79 (Akt activator) 20 min before NMDA or vehicle application. Lysates were prepared 10 min after NMDA washout and immunoprecipitated with
Ago2 antibodies or control IgG as shown. Proteins were detected by Western blotting. The inputs are shown in (D). Graph shows quantification of Ago2-GW182
interaction, normalised to vehicle control; n = 4.
D Further evidence that the NMDAR-stimulated increase in Ago2 phosphorylation at S387 is Akt-dependent. The same lysates from (C) (1% of input) were analysed by
Western blotting. Graph shows quantification of pS387 Ago2 levels normalised to total Ago2; n = 4.
E NMDAR-stimulated increase in Ago2-GW182 interaction is p38 MAP kinase-independent. Cortical neuronal cultures were treated with Akti-1/2 or SB203580 (p38MAPK
inhibitor) 20 min before NMDA or vehicle application. Lysates were prepared 10 min after NMDA washout and immunoprecipitated with Ago2 antibodies or control
IgG as shown. Proteins were detected by Western blotting. The inputs are shown in (F). Graph shows quantification of Ago2-GW182 interaction, normalised to vehicle
control; n = 4.
F NMDAR-stimulated increase in Ago2 phosphorylation at S387 is p38 MAP kinase-independent. The same lysates from (E) (1% of input) were analysed by Western
blotting. Graph shows quantification of pS387 Ago2 levels normalised to total Ago2; n = 4.
Data information: *P < 0.05; **P < 0.01; ***P < 0.001; two-way ANOVA, Bonferroni post hoc test. Mean  SEM.
Source data are available online for this figure.
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Appendix Fig S2). This suggests that NMDAR-dependent phospho-
rylation of Ago2 at S387 does not depend on prior dissociation
from PICK1.
In a complementary set of experiments, we used confocal
imaging of the same GFP-tagged Ago2 constructs to analyse
their co-localisation with endogenous GW182. While all three
A
B
Figure 3. NMDA-induced increase in interaction with GW182 is caused by Ago2 phosphorylation at S387.
A Ago2 S387A mutation blocks, and S387D mutation occludes NMDA-induced increases in GW182 and DDX6 interactions. Cortical neurons were transfected with
molecular replacement constructs expressing Ago2 shRNA plus shRNA-resistant GFP-Ago2 (WT, S387A or S387D). Lysates were prepared 10 min after NMDA washout,
and GFP-Ago2 complexes were precipitated using GFP-trap beads. Bound proteins were detected by Western blotting using GFP, GW182, MOV10, DDX6 or PICK1
antibodies as shown. Graphs show quantification of GFP-Ago2 interactions, normalised to untreated WT condition; n = 5. *P < 0.05, **P < 0.01; two-way ANOVA,
Bonferroni post hoc test. Mean  SEM.
B Ago2 S387A mutation blocks, and S387D mutation occludes NMDA-induced increase in GW182 co-localisation in neuronal dendrites. Cortical neurons were
transfected with molecular replacement constructs expressing Ago2 shRNA plus shRNA-resistant GFP-Ago2 (WT, S387A or S387D), fixed 10 min after NMDA washout,
permeabilised and stained with GW182 and GFP antibodies. Graph shows Pearson’s co-localisation coefficients; n = 4 independent experiments (11 cells per
condition). *P < 0.05, **P < 0.01; two-way ANOVA, Bonferroni post hoc test. Scale bar = 10 lm. Mean  SEM.
Source data are available online for this figure.
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GFP-Ago2 proteins co-localised with GW182 puncta, GFP-S387D-
Ago2 showed significantly more co-localisation than GFP-WT-Ago2,
and only GFP-WT-Ago2 showed an increase in co-localisation
following NMDAR stimulation (Fig 3B).
These results demonstrate that Ago2-GW182 interactions in
neuronal dendrites are dynamically regulated by phosphorylation of
Ago2 at S387 in response to NMDAR stimulation.
Transient increase in GW182-Ago2 interaction and Ago2
phosphorylation at S387 in response to NMDAR stimulation
Our results so far indicate that the increases in Ago2 phosphoryla-
tion and GW182 binding take place within 10 min after NMDAR
stimulation. To better understand the time course of these
changes following stimulation, we analysed Ago2 phosphorylation
at S387 and endogenous Ago2-GW182 binding at 0, 3, 6, 10 and
20 min after stimulation. Ago2-GW182 binding transiently
increased following NMDAR stimulation, with a peak at 6 min
after stimulation (Fig 4A). The increase in Ago2 phosphorylation
at S387 showed a similar time course with maximum phosphory-
lation at 6 min (Fig 4B). Both of these changes remained signifi-
cantly elevated at 10 min after stimulation and returned to
baseline levels by 20 min. These results demonstrate that GW182-
Ago2 binding is transiently enhanced by NMDAR stimulation, and
the strengthened complex lasts for approximately 10 min. Our
results presented in Fig 2 suggest that Akt is activated in response
to NMDAR stimulation. We tested this directly using an Akt phos-
pho-specific antibody against pS473, which is a well-established
marker for activated Akt (Perkinton et al, 2002; Sutton &
Chandler, 2002). NMDAR stimulation caused a similar transient
increase in Akt activation, which peaked slightly earlier, at 3 min
after stimulation (Fig 4B), consistent with a mechanism in which
Akt activity is upstream of Ago2 phosphorylation and GW182
binding.
A
B
Figure 4. Transient increase in GW182-Ago2 interaction and S387 phosphorylation in response to NMDAR stimulation.
A Transient increase in Ago2-GW182 interaction. Cortical neuronal cultures were exposed to NMDA or vehicle for 3 min, and lysates were prepared 0, 3, 6, 10, 20 min
after NMDA washout and immunoprecipitated with Ago2 antibodies or control IgG. Proteins were detected by Western blotting. The inputs are shown in (B). Graph
shows quantification of Ago2-GW182 interaction, normalised to vehicle control; n = 4. **P < 0.01, ***P < 0.001; one-way ANOVA, Bonferroni post hoc test.
Mean  SEM.
B Transient increase in S387 phosphorylation and Akt activation. The same lysates from (A) (1% of input) were analysed by Western blotting using antibodies against
pS387 Ago2, Ago2, pS473 Akt, Akt, GW182 and GAPDH as a loading control. Graphs show quantification of pS387 Ago2 levels normalised to total Ago2 (top) and pS473
Akt normalised to total Akt (bottom); n = 4. *P < 0.05; two-way ANOVA, Bonferroni post hoc test. Mean  SEM.
Source data are available online for this figure.
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NMDAR-dependent translational repression via miR-134 is
regulated by Ago2 phosphorylation at S387
To investigate the effect of increasing the pS387-dependent Ago2-
GW182 interaction on miRNA-mediated translational repression, we
employed dual-luciferase assays, with Renilla control and Firefly
reporter constructs incorporating 30UTRs of known targets of
endogenous miRNAs. In these assays, a decrease in luciferase activ-
ity represents an increase in miRNA-mediated translational repres-
sion (and vice versa). We analysed two dendritically regulated
UTRs; LIMK1, which is regulated by miR-134 (Schratt et al, 2006),
and APT1, which is regulated by miR-138 (Siegel et al, 2009). Both
of these miRNAs have been shown previously to regulate dendritic
spine morphology (Schratt et al, 2006; Siegel et al, 2009), and we
previously demonstrated that NMDAR activation increased transla-
tional repression of the LIMK1 reporter via miR-134 and of the APT1
reporter via miR-138 within 10 min after stimulation (Antoniou
et al, 2014; Rajgor et al, 2017). Knockdown of Ago2 by shRNA
caused a dramatic increase in expression of both reporter
constructs, consistent with a deficit of miRNA-mediated transla-
tional repression, and NMDAR stimulation had no effect under these
conditions (Fig 5A and B). The expression levels of Ago1 and Ago3
were unaffected by Ago2 knockdown (Appendix Fig S3A), indicat-
ing that these other isoforms were not up-regulated to compensate
for the loss of Ago2. Co-expression of sh-resistant GFP-WT-Ago2
fully rescued both the basal level of luciferase reporter expression,
as well as the sensitivity to NMDAR stimulation (Fig 5A and B),
indicating that the slight overexpression of Ago2 with the molecular
replacement constructs (see Appendix Fig S1) had no functional
impact on miRNA activity. Co-expression of Ago1 did not rescue the
functional deficit caused by Ago2 knockdown (Appendix Fig S3B).
Interestingly, molecular replacement with S387 mutants had distinct
effects on LIMK1 silencing by miR-134 compared to APT1 silencing
via miR-138. GFP-S387A-Ago2 expression caused a significant
increase in basal expression of the LIMK1 reporter, suggesting
reduced RISC activity, whereas GFP-S387D-Ago2 expression caused
a significant decrease in LIMK1 reporter expression, indicative of
increased RISC activity. Both S387 mutants abolished NMDAR-
dependent changes in LIMK1 reporter expression (Fig 5A). These
results indicate that the NMDA-induced regulation of LIMK1 silenc-
ing via miR-134 depends on the dynamic phosphorylation of Ago2
at S387. In contrast, basal expression of the APT1 reporter and
sensitivity to NMDA were unaffected by the S387 mutations;
cultures expressing molecular replacement constructs for GFP-
S387A-Ago2, GFP-S387D-Ago2 and GFP-WT-Ago2 all showed
patterns of luciferase expression under basal and stimulated condi-
tions that were indistinguishable from controls (Fig 5B). This indi-
cates that translational repression of APT1 via miR-138 activity is
regulated by a mechanism that does not require S387 phosphoryla-
tion. In addition, we analysed a further luciferase reporter construct
incorporating the LIN41 30UTR, which is a target for the miRNA
Let7. In contrast to miR-134 and miR-138, Let7 has not been shown
to be targeted to dendrites. While expression of the LIN41 reporter
was increased by Ago2 shRNA, it was unaffected by NMDAR activa-
tion and unaffected by S387 mutation (Fig 5C).
These results suggested that the regulation of translational
repression via S387 phosphorylation depends either on a specific
property of miR-134, or alternatively on a specific property of the
LIMK1 30UTR. To investigate this further, we analysed the expres-
sion of luciferase reporters incorporating the 30UTRs of PUM2 and
CREB1, which have been shown previously to be regulated by miR-
134 (Fiore et al, 2014). Interestingly, while both reporters were
sensitive to Ago2 shRNA, neither was affected by molecular replace-
ment with S387 mutants (Fig 5D and E). This suggests that specific
characteristics of the LIMK1 30UTR, which are distinct from the
CREB1 and PUM2 30UTRs, are necessary for translational regulation
via Ago2 phosphorylation at S387.
Importantly, to confirm that the observed changes in reporter
expression were miRNA-dependent, we performed parallel experi-
ments with reporter constructs carrying mutations in the miR-134,
miR-138 or Let7 seed regions of LIMK1, APT1 or LIN41 30UTRs,
respectively, to prevent miRNA binding (Storchel et al, 2015;
Fig EV3A–C; Appendix Fig S4A–C). Indeed, all translational control
over the luciferase constructs was abolished by these mutations,
supporting our conclusions that the observed changes are caused by
altered miR-134, miR-138 and Let-7 activity, respectively. Interest-
ingly, while reporter constructs incorporating PUM2 and CREB1
30UTRs with mutated miR-134 seed regions were insensitive to
NMDAR stimulation and to S387 mutations, Ago2 shRNA did cause
an increase in luciferase activity (Fig EV3F and G; Appendix Fig
S4D and E). This suggests that PUM2 and CREB1 are subject to regu-
lation by additional miRNAs apart from miR-134, whereas LIMK1
translation is selectively repressed by miR-134.
Since our results presented in Fig 2 suggest that Akt phosphory-
lates S387 in response to NMDAR stimulation, we analysed the
effect of Akt inhibition on luciferase reporter expression. Both Akt
inhibitors Akti-1/2 and KP372-1 caused a decrease in basal silencing
of LIMK1 via miR-134 and also blocked the NMDAR-stimulated
increase in miRNA activity, while PKC inhibition (chelerythrine)
and GSK3b inhibition (CT99021) had no effect (Fig 5F). In contrast,
miR-138 activity was unaffected by any of these inhibitors (Fig 5G),
which is consistent with our observations that S387 mutants had no
effect on APT1 silencing via miR-138. None of the inhibitors affected
expression of luciferase reporter constructs carrying mutations in
the 30UTR to block binding of miRNA (Fig EV3D and E).
Taken together, these results strongly suggest that NMDAR stim-
ulation causes a rapid up-regulation of miR-134-dependent LIMK1
silencing via Akt-mediated phosphorylation of Ago2 at S387. APT1
silencing via miR-138 activity is also up-regulated by NMDAR stimu-
lation, but is controlled by an alternative mechanism.
Phospho-regulation of Ago2 at S387 mediates NMDA-stimulated
translational repression of endogenous LIMK1 in dendrites
LIMK1 is a key component of a signalling pathway that controls
actin polymerisation in several cellular processes, including
dendritic spine morphogenesis (Hotulainen & Hoogenraad, 2010;
Fortin et al, 2012). It has been shown previously that LIMK1 dele-
tion results in smaller spine heads, and LIMK1 overexpression
blocks NMDA-induced shrinkage of dendritic spines (Meng et al,
2002; Calabrese et al, 2014), suggesting that LIMK1 plays an impor-
tant role in maintaining spine size, or restricting spine shrinkage. A
previous report demonstrated that endogenous LIMK1 protein
expression is down-regulated by miR-134 in neurons (Schratt et al,
2006), and our luciferase reporter assay results suggest that LIMK1
translation is regulated by an NMDAR-dependent mechanism that
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Figure 5. MiR-134-mediated LIMK1 silencing is regulated by Akt-dependent Ago2 phosphorylation at S387 in response to NMDAR stimulation.
A–C Silencing of LIMK1 via miR-134 (A), but not APT1 via miR-138 (B) or LIN41 via Let7 (C), is regulated by S387 phosphorylation. Cultured cortical neurons transfected
with Ago2 molecular replacement constructs as well as Renilla luciferase and Firefly luciferase reporters containing LIMK1 (A), APT1 (B) or LIN41 (C) 30UTRs were
treated with NMDA or vehicle for 3 min. 10 min after NMDA washout, lysates were prepared for dual-luciferase assays.
D, E Silencing of miR-134 targets PUM2 and CREB1 is unaffected by S387 phosphorylation and NMDAR stimulation. Cultured cortical neurons transfected with Ago2
molecular replacement constructs as well as Renilla luciferase and Firefly luciferase reporters containing PUM2 (D), CREB1 (E) 30UTRs were treated with NMDA or
vehicle for 3 min. 10 min after NMDA washout, lysates were prepared for dual-luciferase assays.
F, G NMDAR-dependent silencing of LIMK1 via miR-134 (D), but not APT1 via miR-138 (E), is Akt-dependent. Cultured cortical neurons transfected with Ago2 molecular
replacement constructs as well as Renilla luciferase and Firefly luciferase reporter containing LIMK1 (D) or APT1 (E) 30UTR were treated with inhibitors as shown
20 min before NMDA or vehicle. 10 min after NMDA washout, lysates were prepared for dual-luciferase assays.
Data information: All graphs show Luciferase/Renilla ratios, normalised to vehicle control; n = 5. *P < 0.05; **P < 0.01; ***P < 0.001; two-way ANOVA, Bonferroni post hoc
test. Mean  SEM.
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involves Ago2 phosphorylation at S387. We therefore hypothesised
that increased RISC activity caused by Ago2 phosphorylation at
S387 is involved in NMDA-stimulated spine shrinkage via transla-
tional repression of LIMK1.
To test this hypothesis, we asked whether endogenous LIMK1 is
regulated in a similar manner as the LIMK1 30UTR luciferase reporter.
We initially performed a time course experiment to investigate LIMK1
expression after NMDAR stimulation. Consistent with our luciferase
assays, we observed a significant reduction in LIMK1 protein within
the first 10 min after stimulation, which was further diminished to
< 50% of control levels by 40 min (Fig 6A). Furthermore, inhibition
of Akt with Akti-1/2 caused a significant block of NMDAR-dependent
down-regulation of LIMK1 expression at 40 min (Fig 6B), demon-
strating a requirement for Akt activation, and suggesting a role for
regulation of Ago2 by S387 phosphorylation. In the light of our strik-
ing luciferase assay results, we also analysed expression of endoge-
nous APT1 (acyl protein thioesterase 1), which is involved in
dendritic spine morphogenesis by modulating the palmitoylation of
synaptic proteins (Siegel et al, 2009). In agreement with our luci-
ferase assays, APT1 protein expression was reduced by NMDAR stim-
ulation (Fig EV4A), while Akt inhibition had no effect (Fig EV4B).
To directly investigate a role for Ago2 phosphorylation at S387,
we used immunocytochemistry to analyse LIMK1 protein in
dendrites of neurons transfected with Ago2 molecular replacement
constructs. In control neurons expressing GFP, NMDAR stimulation
caused a significant decrease in LIMK1 expression 40 min after stim-
ulation (Fig 6C). In neurons expressing Ago2 shRNA, LIMK1 expres-
sion under basal conditions was increased compared to controls and
was unaffected by NMDAR stimulation (Fig 6C). ShRNA-resistant
GFP-WT-Ago2 rescued basal LIMK1 levels and the NMDAR-stimu-
lated decrease in expression seen in control neurons. Molecular
replacement with GFP-S387A-Ago2 caused a small but significant
increase in basal LIMK1 expression, while GFP-S387D-Ago2 caused
a corresponding decrease in LIMK1. NMDA had no effect on LIMK1
expression in neurons expressing either S387 mutant (Fig 6C). We
carried out equivalent experiments to analyse NMDAR-dependent
changes in APT1 protein expression in neuronal dendrites express-
ing Ago2 S387 mutants. While dendritic APT1 was reduced by
NMDAR stimulation, S387 mutations had no effect (Fig EV4C).
These results strongly suggest that an NMDAR-stimulated increase
in translational repression via Ago2 S387 phosphorylation causes a
reduction in endogenous LIMK1 expression, but not APT1 expres-
sion, in neuronal dendrites.
To investigate de novo synthesis of endogenous LIMK1, we used
puromycin-proximity ligation assays (Puro-PLA), which exploits the
incorporation of puromycin into newly synthesised polypeptides,
which can be labelled with an anti-puromycin antibody at the same
time as an antibody against LIMK1. A PLA signal reports the close
(< 5 nm) proximity of puromycin and LIMK1 antibodies and hence a
site of newly synthesised protein (tom Dieck et al, 2015; Sambandan
et al, 2017). Puro-LIMK1 PLA puncta were readily detectable in the
dendrites of cultured neurons incubated with puromycin. In contrast,
PLA signal was absent in control cells that were not exposed to puro-
mycin (Fig 6D). NMDA caused a significant reduction in the number
of puncta at 40 min after stimulation, demonstrating that endogenous
LIMK1 translation is reduced by NMDAR stimulation within this time
frame. Ago2 knockdown by shRNA caused a significant increase in
the density of Puro-LIMK1 PLA puncta in dendrites, consistent with a
reduction in miRNA-mediated translational repression. NMDA had
no effect on the density of puncta in neurons expressing Ago2
shRNA, indicating that the NMDAR-dependent reduction in LIMK1
translation is miRNA-dependent. Co-expression of sh-resistant GFP-
WT-Ago2 fully rescued both the basal density of Puro-LIMK1 PLA
puncta, as well as the sensitivity to NMDAR stimulation. Molecular
replacement with GFP-S387A-Ago2 caused no change in basal puncta
density, but completely blocked the effect of NMDA, indicating that
Ago2 phosphorylation at S387 is required for the NMDAR-dependent
repression of endogenous LIMK1 translation. This is further
supported by GFP-S387D-Ago2 expression, which caused a reduction
in Puro-LIMK1 PLA puncta under basal conditions and occluded the
effect of subsequent NMDAR stimulation (Fig 6D). These experi-
ments demonstrate that the synthesis of LIMK1 in neuronal dendrites
is down-regulated in a miRNA-dependent manner via a mechanism
that requires Ago2 phosphorylation at S387.
Phospho-regulation of Ago2 at S387 is required for NMDA-
induced spine shrinkage
Next, we analysed NMDA-stimulated dendritic spine shrinkage on
cultured neurons transfected with molecular replacement constructs
▸Figure 6. NMDAR stimulation regulates dendritic LIMK1 translation via Akt activation and Ago2 phosphorylation at S387.A Endogenous LIMK1 protein levels are rapidly reduced in response to NMDAR stimulation. Cortical neuronal cultures were exposed to NMDA or vehicle for 3 min, and
lysates were prepared 10, 20 or 40 min after NMDA washout and analysed by Western blotting. Graphs show quantification of LIMK1 expression normalised to
vehicle control; n = 6. *P < 0.05; **P < 0.01; one-way ANOVA, Bonferroni post hoc test. Mean  SEM.
B NMDAR-dependent decrease in LIMK1 is Akt-dependent. Cortical neuronal cultures were treated with Akti-1/2 20 min before NMDA or vehicle application, and lysates
were prepared 40 min after NMDA washout and analysed by Western blotting. Graphs show quantification of LIMK1 expression normalised to vehicle control; n = 5.
**P < 0.01; ***P < 0.001 one-way ANOVA, Bonferroni post hoc test. Mean  SEM.
C NMDAR-dependent decrease in dendritic LIMK1 expression requires Ago2 phosphorylation at S387. Cortical neurons were transfected with molecular replacement
constructs expressing Ago2 shRNA plus shRNA-resistant GFP-Ago2 (WT, S387A or S387D), fixed 40 min after NMDA washout, permeabilised and stained with LIMK1
antibodies (red channel). GFP signal was maximised at acquisition so that dendrites could be effectively visualised. Graph shows LIMK1 staining intensity in dendrites
normalised to vehicle control; n = 5 independent experiments (10 cells per condition). *P < 0.05; **P < 0.01, two-way ANOVA, Bonferroni post hoc test. Scale
bar = 10 lm. Mean  SEM.
D De novo translation of endogenous LIMK1 is regulated in dendrites by NMDAR stimulation via Ago2 phosphorylation at S387. Cortical neuronal cultures were
transfected with molecular replacement constructs expressing Ago2 shRNA plus shRNA-resistant GFP-Ago2 (WT, S387A or S387D). Neurons were incubated with 1 lM
puromycin in the presence or absence of 50 lM NMDA for 3 min. Following NMDA washout, neurons were incubated with puromycin for 40 min, after which the
cells were fixed and processed for Puro-LIMK1 PLA (see Materials and Methods). Puro-PLA was also performed on GFP-transfected neurons that were not incubated
with puromycin as a negative control (bottom row of images). n = 5 independent experiments (10–13 cells per condition). **P < 0.01; ***P < 0.001 two-way ANOVA,
Bonferroni post hoc test. Scale bar = 10 lm. Mean  SEM.
10 of 21 The EMBO Journal e97943 | 2018 ª 2018 The Authors
The EMBO Journal Ago2 phosphorylation and spine plasticity Dipen Rajgor et al
Published online: April 30, 2018 
AC
D
B
Figure 6.
ª 2018 The Authors The EMBO Journal e97943 | 2018 11 of 21
Dipen Rajgor et al Ago2 phosphorylation and spine plasticity The EMBO Journal
Published online: April 30, 2018 
to express GFP-tagged Ago2 S387 mutants. In control cells express-
ing GFP, NMDAR activation caused spine shrinkage of ~ 25% at
40 min after stimulation (Fig 7A). Surprisingly, Ago2 knockdown
by shRNA had no effect on basal spine size, nor on NMDA-stimu-
lated spine shrinkage (Fig 7A). However, molecular replacement
with GFP-S387A-Ago2 caused a significant increase in basal spine
size and GFP-S387D-Ago2 caused a significant decrease in basal
spine size. Furthermore, NMDA-stimulated spine shrinkage was
abolished in neurons expressing either mutant (Fig 7A). These
results show that phosphorylation of Ago2 at S387 is an essential
component of NMDAR-dependent dendritic spine shrinkage,
suggesting that Akt activity is required for this process. To test this
directly, we applied the Akt inhibitor Akti-1/2 during and after
NMDAR stimulation and analysed spine size 40 min later. Akti-1/2
completely blocked NMDA-induced spine shrinkage (Fig 7B).
Analysis of spine density indicated that NMDAR stimulation had
no significant effect under these experimental conditions. However,
Ago2 shRNA did cause a significant increase in spine density, a
phenotype that was fully rescued by GFP-WT-Ago2, GFP-S387A-
Ago2 or GFP-S387D-Ago2 (Fig 7A), suggesting that S387 phosphory-
lation is not involved in regulating spine density.
Taken together, these results demonstrate that phospho-regula-
tion of Ago2 at S387 by Akt is required for NMDA-induced spine
shrinkage, but is not involved in regulating spine density. Consider-
ing these data in conjunction with our results for LIMK1 translation
(Figs 5 and 6) leads to the hypothesis that the down-regulation of
LIMK1 synthesis is a critical component of the mechanism that
underlies NMDA-induced spine shrinkage. To test this, we used a
myc-tagged LIMK1 construct that does not contain the native LIMK1
30UTR and is therefore resistant to regulation by miR-134. NMDA-
induced spine shrinkage is abolished in neurons expressing
mycLIMK1 (Fig 7C), strongly suggesting that a reduction in LIMK1
expression is required for spine shrinkage.
Phospho-regulation of Ago2 at S387 is not involved in NMDAR-
stimulated AMPAR trafficking
In addition to spine shrinkage, LTD involves a removal of AMPARs
from synapses, caused by increased receptor endocytosis from the cell
surface and regulation in the endosomal system (Anggono & Huganir,
2012). Since our results demonstrate that NMDAR-dependent
phosphorylation of Ago2 is required for spine shrinkage, we also
investigated whether the same mechanism is required for AMPAR
trafficking, using immunocytochemistry to label surface-expressed
GluA2-containing AMPARs. Interestingly, neither Ago2 shRNA nor
molecular replacement with S387 mutants had a significant effect on
basal levels of surface GluA2, suggesting that GluA2 is not regulated
by phosphorylation of Ago2 at S387 under basal conditions
(Fig EV5A). NMDAR stimulation caused a significant loss of surface
AMPARs, analysed at 20 min after stimulation, which was similar in
all transfection conditions, indicating that NMDA-induced AMPAR
internalisation is not regulated by phosphorylation at S387. We also
analysed total levels of AMPAR subunits GluA1 and GluA2 at 0, 10,
20 and 40 min after NMDAR stimulation. GluA1 has previously been
shown to be translationally repressed by miR501-3p in an NMDAR-
dependent manner (Hu et al, 2015), while a miRNA-dependent
regulation of GluA2 translation in response to NMDAR stimulation
has not, to our knowledge, been reported. In contrast to LIMK1,
expression levels of GluA1 and GluA2 were not rapidly down-regu-
lated at 10 min. While GluA1 showed a significant reduction in
expression at 40 min after stimulation, GluA2 expression did not
change (Fig EV5B). Furthermore, Akt inhibition had no effect on the
NMDA-induced decrease in GluA1 expression (Fig EV5C).
These results indicate that neither NMDAR-stimulated AMPAR
internalisation nor modulation of AMPAR subunit expression is
controlled by Akt-dependent S387 phosphorylation of Ago2.
Phospho-regulation of Ago2 at S387 is not required for CA3-CA1 LTD
To investigate the role of Ago2 phosphorylation in the context of
synaptic physiology, we analysed basal synaptic transmission and
LTD at CA3-CA1 synapses in organotypic hippocampal slices. We used
a gene gun to transfect cells with Ago2 shRNA or molecular replace-
ment plasmids. To analyse effects on basal synaptic transmission, we
recorded AMPAR EPSCs from transfected (fluorescent) CA1 pyramidal
cells and neighbouring untransfected cells in response to the same
synaptic stimulus. Ago2 knockdown by shRNA did not significantly
alter EPSC amplitude; however, molecular replacement with GFP-
S387A-Ago2 caused a significant increase in EPSC amplitude, while
GFP-S387D-Ago2 caused a significant decrease (Fig 8A–H).
To directly explore the role of Ago2 phosphorylation in synaptic
plasticity, we carried out recordings from CA1 pyramidal cells, and
▸Figure 7. NMDA-induced dendritic spine shrinkage requires Akt activation, Ago2 phosphorylation at S387 and miRNA-mediated reduction in LIMK1expression.
A S387 phosphorylation is required for NMDA-induced spine shrinkage. Cortical neurons were co-transfected with mRUBY as a morphological marker, and molecular
replacement constructs expressing Ago2 shRNA plus shRNA-resistant GFP-Ago2 (WT, S387A or S387D). Forty minutes after NMDA or vehicle application, cells were
fixed, permeabilised and stained with anti-mCherry antibody to amplify the mRUBY signal, from which spine size and density were measured. Graph shows
quantification of spine size and spine density; n = 4 independent experiments (nine cells per condition). *P < 0.05; **P < 0.01; ***P < 0.001; two-way ANOVA,
Bonferroni post hoc test. Scale bar = 10 lm. Mean  SEM.
B Akt activation is required for NMDA-induced spine shrinkage. Cortical neurons were transfected with GFP as a morphological marker, and Akti-1/2 was applied
20 min before NMDA or vehicle application. Forty minutes after NMDA washout, cells were fixed, and spine size and density were measured. Graph shows
quantification of spine size and spine density; n = 4 independent experiments (10 cells per condition). *P < 0.05; two-way ANOVA, Bonferroni post hoc test. Scale
bar = 10 lm. Mean  SEM.
C Loss of LIMK1 is required for NMDA-induced spine shrinkage. Cortical neurons were co-transfected with mRUBY as a morphological marker, and mycLIMK1 or empty
vector. Forty minutes after NMDA or vehicle application, cells were fixed, permeabilised and stained with anti-myc antibody (green) and anti-mCherry antibody
(magenta) to amplify the mRUBY signal, from which spine size and density were measured. Graphs show quantification of spine size (left), spine density (middle) and
mycLIMK1 expression (right); n = 5 independent experiments (10 cells per condition). *P < 0.05; two-way ANOVA, Bonferroni post hoc test. Scale bar = 10 lm.
Mean  SEM.
Source data are available online for this figure.
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a low-frequency stimulation pairing protocol was used to induce
NMDAR-dependent LTD (Rocca et al, 2013). Reliable LTD of
AMPAR EPSCs was induced in control non-transfected cells but
was completely blocked in neurons expressing Ago2 shRNA
(Fig 8I and J), indicating that LTD expression requires miRNA
activity. LTD was rescued by co-expression of sh-resistant GFP-
WT-Ago2, GFP-S387A-Ago2 or GFP-S387D-Ago2 (Fig 8K–N),
demonstrating that regulation of Ago2 function by phosphoryla-
tion at S387 is not involved in CA3-CA1 LTD. Taken together
with our results for AMPAR surface expression, this strongly
suggests that, in the context of NMDAR-dependent plasticity, this
mechanism is specifically involved in regulating dendritic spine
size.
Discussion
Here, we define a mechanism for rapidly increasing miRNA-
mediated translational repression in response to NMDAR stimula-
tion. We show that Ago2 phosphorylation at S387 is transiently
increased by NMDAR activation via an Akt-dependent pathway,
which enhances the interaction between Ago2 and GW182. Func-
tionally, this mechanism reduces translation of the actin-regulatory
protein LIMK1 in neuronal dendrites via miR-134 and has a specific
functional role in plasticity. NMDA-induced spine shrinkage is
blocked by the Ago2 phospho-null S387A mutant, and a phospho-
mimic mutant S387D causes basal spine shrinkage that occludes
subsequent plasticity. In contrast, AMPAR internalisation and LTD
are unaffected by S387 mutants, suggesting that this is a specific
mechanism for structural plasticity.
Ago2 phosphorylation and protein interactions
Our results strongly suggest that the molecular basis for the modu-
lation of Ago2 function by S387 phosphorylation in neurons is via
regulation of GW182 binding. In agreement with our results, a
previous study demonstrated that S387 phosphorylation in HeLa
cells increased Ago2-GW182 binding and had no effect on miRNA
loading (Horman et al, 2013). While S387 is situated between the
PAZ and MID domains of Ago2, GW182 associates with the PIWI
domain towards the C-terminus of Ago2 (Pfaff et al, 2013),
suggesting that phosphorylated S387 is unlikely to contribute to
the GW182 binding site directly. A recent study provides an expla-
nation for this by demonstrating that the LIM-domain protein
LIMD1 binds both GW182 and S387-phosphorylated Ago2 in HeLa
cells and stabilises the interaction between Ago2 and GW182 in
response to Ago2 phosphorylation (Bridge et al, 2017). Interest-
ingly, this report further suggests that DDX6 is also recruited to
Ago2 by S387 phosphorylation, presumably by interacting with
GW182 following LIMD1 binding. In agreement with this observa-
tion, our results show that NMDAR stimulation and consequent
S387 phosphorylation also enhance Ago2-DDX6 association in
neurons. We also show that the interaction of MOV10 with Ago2
is insensitive to NMDAR stimulation and S387 phosphorylation,
suggesting only specific Ago2 complexes are regulated in an activ-
ity-dependent manner.
While Ago2 contains several phosphorylation sites, there are
few reports defining the phospho-regulation of Ago2 in specific
physiological contexts, and not all of the proposed phosphoryla-
tion sites have been assigned a function. Previous reports have
demonstrated that Ago2 phosphorylation at Y529 regulates small
miRNA binding (Rudel et al, 2011; Mazumder et al, 2013), and
phosphorylation at Y393 regulates Ago2-Dicer interactions (Shen
et al, 2013). More recently, phosphorylation of a C-terminal clus-
ter of serine and threonine residues in Ago2 has been shown to
regulate mRNA binding (Que´villon Huberdeau et al, 2017).
Numerous kinases and phosphatases are implicated in synaptic
plasticity, and further work is needed to define how various
aspects of RISC function might be regulated to control protein
translation for plasticity.
▸Figure 8. CA3-CA1 LTD does not involve phospho-regulation of Ago2 at S387.A Ago2 knock down has no effect on basal synaptic transmission. EPSCs from a neuron transfected with Ago2 shRNA and a neighbouring untransfected control neuron
in response to identical stimulation are plotted (n = 13 pairs). White dots = individual comparisons, grey dot = mean responses  SEM. Insets show representative
traces. Calibration bars: 20 pA, 50 ms.
B Quantification of experiments shown in (A). Values are mean  SEM.
C Molecular replacement with GFP-WT-Ago2 has no effect on basal synaptic transmission. EPSCs from a neuron transfected with Ago2 shRNA plus GFP-WT-Ago2 and a
neighbouring untransfected neuron in response to identical stimulation are plotted (n = 13). Black dots = individual comparisons, grey dot = mean
responses  SEM. Calibration bars: 20 pA, 50 ms.
D Quantification of experiments shown in (C). Values are mean  SEM.
E Molecular replacement with GFP-S387A-Ago2 increases basal synaptic transmission. EPSCs from a neuron transfected with Ago2 shRNA plus GFP-S387A-Ago2 and a
neighbouring untransfected neuron in response to identical stimulation are plotted (n = 13). Black triangles = individual comparisons, grey triangle = mean
responses  SEM. Calibration bars: 20 pA, 40 ms.
F Quantification of experiments shown in (E). **P < 0.01, paired t-test. Error bars represent mean  SEM.
G Molecular replacement with GFP-S387D-Ago2 decreases basal synaptic transmission. EPSCs from a neuron transfected with Ago2 shRNA plus GFP-S387D-Ago2 and a
neighbouring untransfected neuron in response to identical stimulation are plotted (n = 14). Black squares = individual comparisons, grey square = mean
responses  SEM. Calibration bars: 20 pA, 50 ms.
H Quantification of experiments shown in (G). Values are mean  SEM. *P < 0.05, paired t-test.
I A pairing protocol (360 pulses at 1 Hz, delivered while the neuron is held at 40 mV) results in LTD in untransfected neurons (n = 9). Calibration bars for this and all
following example traces: 50 pA, 50 ms. Error bars are mean  SEM.
J LTD is blocked in neurons transfected with Ago2 shRNA (n = 6). Error bars are mean  SEM.
K Co-expression of sh-resistant GFP-WT-Ago2 rescues the block of LTD (n = 5). Error bars are mean  SEM.
L Co-expression of GFP-S387A-Ago2 rescues the block of LTD (n = 5). Error bars are mean  SEM.
M Co-expression of GFP-S387D-Ago2 rescues the block of LTD (n = 5). Error bars are mean  SEM.
N Summary LTD data in panels (I–M). * P < 0.05, one-way ANOVA followed by post hoc Bonferroni correction. Error bars are mean  SEM.
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NMDAR-dependent miRNA activity
A role for miRNAs in NMDAR-dependent synaptic plasticity has been
emerging over the past 5 years, and specific miRNAs have been iden-
tified that are required for dendritic spine shrinkage and changes in
AMPAR trafficking or expression. For example, a recent study
demonstrated that molecular interventions to inhibit the activity of
miR-135 block NMDA-induced spine shrinkage at 30 min after stim-
ulation (Hu et al, 2014). While miR-135 (as well as numerous other
miRNAs) is up-regulated in response to cLTD induction, transcrip-
tional up-regulation and subsequent processing to mature miRNAs
were not detectable until 1 h after stimulation (Hu et al, 2014,
2015). These studies suggest that transcriptional/maturational up-
regulation of miRNA expression is not fast enough to play a role in
NMDAR-dependent plasticity that is expressed in the first 30 min
after stimulation, and is likely to play an important role in later
stages of plasticity. A key feature of the mechanism we define here is
the speed of translational control. NMDAR stimulation caused signif-
icant pS387-dependent silencing of the LIMK1 luciferase reporter via
miR-134 at 10 min after stimulation. This timing corresponds to the
increase in S387 phosphorylation and increase in Ago2-GW182 inter-
action, which are both observed by 6 min after stimulation, and
return to baseline by 20 min. Therefore, we propose that enhanced
RISC activity via NMDAR-dependent Ago2 phosphorylation at S387
can mediate the rapid effect of miRNA during the expression of plas-
ticity by acting on pre-existing miRNAs in the vicinity of the up-regu-
lated RISC complex. We show that this mechanism is not involved in
NMDAR-stimulated AMPAR endocytosis, which takes place within
5 min following stimulation (Beattie et al, 2000). Again, this is
consistent with the temporal aspects of our results; an increase in
RISC activity 6 min after stimulation would not be fast enough to
mediate changes in translation to influence such trafficking events.
The NMDAR-stimulated reduction in luciferase activity expressed
from the reporter carrying the LIMK1 30UTR is faster than the reduc-
tion in endogenous LIMK1 expression caused by the same stimulus.
Indeed, luciferase expression was reduced by ~ 50% after 10 min,
whereas endogenous LIMK1 expression took ~ 40 min to reach the
same level. This difference is likely to reflect differences in the rate
of degradation of luciferase compared to LIMK1. Since Ago2 S387
mutations block or occlude the observed NMDAR-stimulated reduc-
tion in luciferase activity and the constructs carrying mutations in
the miRNA seed regions are unaffected by NMDAR stimulation, it is
unlikely that luciferase degradation is itself stimulated by NMDA
and suggests that luciferase has a very rapid turnover time in
neurons. While Ago2-GW182 interactions dissociate to baseline
levels by 20 min after stimulation, the drop in endogenous LIMK1
expression continues until 40 min. Delays between increased RISC
activity and reductions in LIMK1 expression might be explained by
the time taken for the degradation of existing protein. Moreover, it
is unclear how rapidly translation would return to pre-stimulation
levels following dissociation of Ago2-GW182 interactions.
While detectable increases in the endogenous mature forms of
specific miRNAs are not seen until 1 h after NMDA stimulation (Hu
et al, 2014, 2015), a recent report used an exogenous pre-miRNA
fluorescent probe to demonstrate that Dicer activity can be detected
in dendrites within a few seconds after stimulation by glutamate
uncaging, suggesting that post-transcriptional miRNA maturation can
be increased very rapidly (Sambandan et al, 2017). It will be of great
interest to determine which miRNAs are processed in this manner,
and how this mechanism contributes to the silencing of endogenous
proteins during processes such as spine structural plasticity.
Our results show that not all dendritically localised miRNA activi-
ties are regulated by this mechanism. While silencing of the luciferase
reporter incorporating the LIMK1 30UTR by miR-134 and of the
reporter containing the APT1 30UTR by miR-138 were both up-regu-
lated by NMDAR stimulation, only LIMK1 silencing by miR-134 was
sensitive to S387 mutations in Ago2. Importantly, silencing of the
luciferase reporters incorporating the PUM2 or CREB1 30UTR, both of
which are partly mediated by miR-134, is insensitive to S387 muta-
tions. This suggests that a specific, but as yet undefined characteristic
of the LIMK1 30UTR is critical for regulation by S387 phosphorylation.
Our results suggest that LIMK1 and APT1 are targeted in neurons
only by miR-134 and miR-138, respectively. In contrast, PUM2 and
CREB1 are silenced by miR-134 as well as additional miRNAs that
require Ago2 activity. While additional miRNAs have been shown
to target LIMK1 in cancer cells (Li et al, 2017), we are not aware of
miRNAs that regulate LIMK1 or APT1 in neurons, apart from miR-
134 and mir-138, respectively.
Regulation of dendritic spine size
Our results define a mechanism in which an NMDAR-dependent
increase in LIMK1 silencing mediated by Ago2 phosphorylation at
S387 in neuronal dendrites causes spine shrinkage as a result of
reduced LIMK1 translation and consequent effects on the actin
cytoskeleton. In addition, they suggest that complex Ago2-depen-
dent mechanisms are involved in regulating dendritic spine morpho-
genesis. Basal spine size was unaffected by Ago2 knockdown, but
was increased by S387A-Ago2 expression and decreased in neurons
expressing S387D-Ago2. Ago2 knockdown caused increases in
translation of LIMK1 luciferase reporters and of endogenous LIMK1,
suggesting that an alternative Ago family member cannot compen-
sate for the loss of Ago2 in the case of these specific miRNA
activities. Spine morphogenesis is influenced by numerous intercon-
necting signalling pathways, the components of which are transla-
tionally controlled by numerous miRNAs. Importantly, the activity
of some miRNAs causes spine shrinkage, whereas that of others
causes spine growth (Ceman & Saugstad, 2011). For example, miR-
134 and miR-138 both promote spine shrinkage, while miR-132
represses Rho GTPase-activating protein p250GAP and promotes
dendritic development and spine growth (Bicker et al, 2014). There-
fore, we propose that the absence of any detectable effect on spine
size caused by Ago2 knockdown can be explained by the attenua-
tion of several silencing events promoting either spine shrinkage or
spine growth, with little overall change. While silencing of both
LIMK1 and APT1 both promote spine shrinkage, our results show
that only LIMK1 silencing is regulated by S387 phosphorylation.
Therefore, the spine size phenotype resulting from Ago2 molecular
replacement with S387 mutants is likely caused by a specific popula-
tion of silencing events that includes miR-134-mediated silencing of
LIMK1. While this also suggests that Ago2 phosphorylation at S387
does not modulate all silencing events that regulate spine shrinkage,
it is possible that this mode of regulation targets only mRNAs
involved in this process, via specific features of their 30UTRs.
Distinct mechanisms appear to regulate basal spine density,
which was markedly increased by Ago2 knockdown, but was
16 of 21 The EMBO Journal e97943 | 2018 ª 2018 The Authors
The EMBO Journal Ago2 phosphorylation and spine plasticity Dipen Rajgor et al
Published online: April 30, 2018 
insensitive to S387 mutations. This indicates that spine density is
regulated by one or more silencing event(s) whose overall effect is
to restrict spine density in an Ago2-dependent but pS387-indepen-
dent manner.
While Akt has been implicated in processes that affect dendritic
spine morphology (Kumar et al, 2005; Majumdar et al, 2011), and
NMDAR-stimulated activation of Akt has been shown previously
(Perkinton et al, 2002; Sutton & Chandler, 2002; but also see
Shehata et al, 2012), a role for Akt in NMDAR-dependent spine
shrinkage has not, to our knowledge, been shown before. Our
results identify an Akt-mediated pathway modulating miRNA activ-
ity that is specifically involved in controlling dendritic spine size in
response to NMDAR stimulation.
Regulation of synaptic transmission
It has been shown previously that specific miRNAs are required for
the maintenance of synaptic transmission as well as synaptic plastic-
ity, including CA3-CA1 LTD (McNeill & Van Vactor, 2012; Hu et al,
2014; Hu & Li, 2017). Our results indicate that basal phosphoryla-
tion of Ago2 at S387 is involved in restricting EPSC amplitude. This
might be a secondary effect caused by modified dendritic spine size
in neurons expressing S387 mutants. However, while we do not
analyse synaptic GluA2 in our imaging experiments, we show that
dendritic GluA2 surface expression is unaffected by the expression
of Ago2 mutants. Furthermore, it has been shown previously that
LIMK1 depletion does not affect basal synaptic transmission despite
altered spine morphology (Meng et al, 2002). Therefore, an alterna-
tive explanation may be that synaptic transmission is regulated by
other miRNA-dependent silencing events that are modulated by
Ago2 phosphorylation at S387. Ago2 depletion per se had no effect
on basal EPSC amplitude, and we propose a similar explanation as
described above for basal spine size; some miRNA-mediated silenc-
ing events may enhance, while others cause a decrease in EPSC
amplitude. Hence, a loss of all Ago2-dependent silencing events
may have little net effect.
Our results show that Ago2 knockdown by shRNA blocks LTD,
which is consistent with previous work showing that miRNAs are
involved in this type of synaptic plasticity (Hu et al, 2014).
However, LTD does not require phosphorylation of Ago2 at S387,
which is in agreement with a previous study demonstrating that
LTD is normal in hippocampal slices from LIMK1 knockout mice
(Meng et al, 2002). Furthermore, a previous report suggested that
Akt activity is not required for the expression of CA3-CA1 LTD
(Peineau et al, 2009), which is consistent with our observation that
Ago2 S387 mutants have no effect on CA3-CA1 LTD.
In agreement with the electrophysiology data, our results show
that NMDAR-dependent internalisation of GluA2-containing
AMPARs, which is thought to be the major mechanism for LTD
(Beattie et al, 2000; Anggono & Huganir, 2012), is unaffected by
Ago2 S387 mutations, emphasising that distinct pathways control
structural and functional plasticity.
In conclusion, we have defined a mechanism for the rapid trans-
duction of NMDAR stimulation into miRNA-mediated translational
repression. A particularly intriguing aspect of this mechanism is that
Ago2 phosphorylation at S387 regulates some NMDAR-dependent
silencing events but not others, suggesting multiple mechanisms are
at play in controlling miRNA activity, even in response to the same
stimulus. The RISC machinery involves numerous protein–protein
interactions, providing a huge potential for distinct modes of action,
and for regulation via a variety of signalling pathways. Future work
will determine whether other key protein–protein interactions are
subject to regulation by plasticity stimuli or neuromodulators.
Numerous neurological disorders involve aberrant miRNA activity
(Wang et al, 2012; Kocerha et al, 2015), and we propose that the
mechanism we define here, or similar mechanisms for regulation of
RISC activity, might represent targets for therapeutic intervention.
Materials and Methods
DNA constructs
Ago2 knockdown and molecular replacement constructs were
created by ligating sequences corresponding to shAgo2- and shRNA-
resistant Ago2 cDNA into FUGW. shAgo2 oligos: (F: cgcgcccc
TGTTCGTGAATTTGGGATCATTGTACAATGATCCCAAATTCACGA
ACAtttttaat; R: taaaaaTGTTCGTGAATTTGGGATCATTGTACAATGA
TCCCAAATTCACGAACAgggg) were annealed in a thermocycler
and cloned into the AscI and PacI sites of FUGW so its expression
could be driven by the H1 promoter. shAgo2-resistant Ago2 was
created using site-directed mutagenesis (F: TTCAACACAGATCCAT
ACGTAAGAGAGTTCGGCATTATGGTCAAAGATGAGATGAC; R: GT
CATCTCATCTTTGACCATAATGCCGAACTCTCTTACGTATGGATCT
GTGTTGAA) on Myc-Ago2 (kind gift from Dr. Gunter Meister) and
then sub-cloned into FUGW (F: TGATCTTGTACAAA ATGTACTC
GGGAGCCGGCCC; R: AGATCATGTACATCAAGCAAAGTACATGG
TGC) using the BsrGI restriction site on the FUGW vector to create
GFP-Ago2. GFP-Ago2 S387A and S387D mutants were created using
site-directed mutagenesis S387A F: CAAATTGATGCGAAGTGCAG
CTTTCAACACAGATCCATAC; R: GTATGGATCTGTGTTGAAAGCTG
CACTTCGCATCAATTTG. S387D F: CAAATTGATGCGAAGTGCAGA
TTTCAACACAGATCCATAC; R: GTATGGATCTGTGTTGAAATCTGC
ACTTCGCATCAATTTG). mRUBY FUGW was created by replacing
the GFP with mRUBY. Luciferase-LIMK1, APT1, LIN41, CREB1 and
PUM2 30UTRs were kindly provided by Prof. G. Schratt.
Cortical neuronal cultures
Rat embryonic cortical neuronal cultures were prepared using stan-
dard procedures from E18 Wistar rat embryos of either gender bred
in-house. The culture medium was Neurobasal (Gibco) supple-
mented with B27 (Gibco) and 2 mM Glutamax. Neurons were plated
at densities of 100,000 cells per well of 24-well plate, 500,000 cells
per well of a 6-well plate and 900,000 cells per 6-cm dish. Neurons
were transfected with plasmid DNA at 10–13 days in vitro (DIV)
(unless otherwise stated) using Lipofectamine 2000 (Invitrogen) and
used for experiments at DIV 15-18. NMDAR stimulation was by bath
application of 50 lM NMDA plus 20 lM glycine in HBS (140 mM
NaCl, 5 mM KCl, 25 mM HEPES, 1.8 mM CaCl2, 0.8 mM MgCl2
10 mM glucose, pH 7.4) for 3 min at 37°C and harvested or fixed at
specific time points as stated for biochemistry, luciferase assays or
imaging. Cells were treated with signalling inhibitors for 20 min
prior to NMDA application and were present throughout and after
stimulation. Drugs were used at the following concentrations: Akti-
1/2 (10 lM), chelerythrine (5 lM), CT99021 (1 lM), KP 372-1
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(50 nM), Sc79 (100 nM), Wortmannin (10 lM), rapamycin
(50 nM), SB203580 (20 lM). Cultures were incubated with the
drugs for 20 min before NMDA stimulation, throughout stimulation
and post-stimulation until cells were lysed or fixed.
Confocal microscopy and image analysis
Cells grown on coverslips were fixed in 4% paraformaldehyde
(ThermoFisher) in PBS (Sigma) supplemented with 2% sucrose at
RT. Cells were permeabilised in 0.5% NP-40 for 2 min. Coverslips
were blocked in 3% BSA (Sigma) for 1 h and incubated with anti-
Ago2 (kind gift from Dr. Marvin Fritzler, dilution 1:20), anti-GW182
(kind gift from Dr. Marvin Fritzler dilution 1:100), anti-LIMK1 (Cell
Signaling 3842 dilution 1:100), anti-APT1 (Abcam ab91606 dilution
1:200), anti-mCherry (2B Scientific AB0081 dilution 1:400), anti-GFP
(NeuroMab N86/8 dilution 1:200) in 3% BSA for 1 h at RT followed
by incubation with the appropriate secondary antibodies (Alexa-
Fluor 488, 568, 647 ThermoFisher) for 45 min and mounted on
slides using mounting medium (Sigma). Coverslips were imaged on
a Leica SP5 confocal system under a 63×/1.4 NA oil-immersion or
40×/1.25 NA oil-immersion objectives. The Leica application suite
software was used to acquire 0.37-lm stepped Z-stacks throughout
the depth of the cells. Image processing and co-localisation analyses
were performed using ImageJ, with the experimenter blinded to the
experimental condition. At least three independent experiments
were performed, and statistical significance was determined using
either t-tests or ANOVA, as appropriate. For quantifying co-localisa-
tion, the Coloc2 plug-in was used to obtain Pearson’s co-localisation
co-efficient on three randomly selected dendrites per neuron and the
average was used for analysis. Spine sizes and density were
measured along 2 dendrites of a neuron with lengths of greater than
80 lm using mRUBY or GFP signal as the morphological marker.
Levels of Ago2, LIMK1, APT1 and GluA2 in dendrites were quanti-
fied by measuring integrated densities of clusters in at least 2
dendrites per neuron. All error bars on graphs represent standard
error of the mean.
Co-immunoprecipitations
Cells were lysed in IP buffer (0.5% Triton X-100, 150 mM NaCl,
20 mM HEPES, pH 7.4), and 1% of extract was removed for input.
The remaining lysate was pre-cleared with protein G-sepharose
beads (GE Healthcare) at 4°C for 1 h. 400 lg of cell lysate was
incubated with 2 lg of anti-Ago2 antibodies (Cell Signaling 2897)
or control IgG (Millipore 12–370) and pulled down with protein
G-sepharose beads (GE Healthcare) at 4°C for 1 h. The vehicle
control sample was used for the IgG control. Beads were washed
three times (1 min each) in 1 ml IP buffer at 4°C. Bound proteins
were detected by Western blotting.
GFP-trap
For GFP-trap (Chromotek) pull-downs, 6 wells of a 6-well plate of
DIV 10 cortical neurons were transfected with FUGW-GFP-Ago2
constructs and harvested 5 days post-transfection. GFP-trap was
performed according to the manufacturer’s instructions. Briefly,
cells were lysed in 500 ll lysis buffer (10 mM Tris pH 7.5; 150 mM
NaCl; 0.5 mM EDTA; 0.5% NP-40) on ice. 1% was taken as input,
and the remaining extract was incubated with 50 ll of GFP-trap
beads for 1 h at 4°C. The beads were then washed with 500 ll of
wash buffer (10 mM Tris pH 7.5; 150 mM NaCl; 0.5 mM EDTA)
three times (1 min each) at 4°C and bound proteins detected by
Western blotting.
Western blotting
Whole-cell lysates or bound proteins from binding experiments were
resolved by SDS–PAGE and transferred to PVDF using a wet transfer
apparatus and blocked in 5% milk solution or 5% BSA made up in
PBS–Tween. The membranes were blotted with the appropriate
primary and secondary antibodies (see below) and bands were visu-
alised using ECL Western blotting substrates (Thermo Fisher Scien-
tific or GE Healthcare). Where appropriate, the membrane was
stripped with Restore Western Blot Stripping Buffer (ThermoFisher)
and re-probed. Membranes were incubated with the following
primary antibodies overnight at 4°C: anti-Ago2 (Cell Signaling Tech-
nology clone C34C6 dilution 1:1,000), anti-Ago2 (kind gift from Dr.
Marvin Fritzler dilution 1:500), anti-Ago2pS387 (ECM Biosciences
AP5291 dilution 1:1,000), anti-GW182 (Novus Bio NBP1-57134 dilu-
tion 1:1,000), anti-MOV10 (Abcam ab176687 dilution 1:1,000), anti-
DDX6 (Abcam ab45869 dilution 1:1,000), anti-LIMK1 (Cell Signaling
3842 dilution 1:1,000), anti-pan Akt (Cell Signaling 2920 dilution
1:2,000), anti-Akt pS473 (Cell Signaling 4060 dilution 1:2,000), anti-
GluA2 (Synaptic Systems #182103 dilution 1:2,000), anti-GAPDH
(clone 6C5 dilution 1:20,000), anti-GFP (NeuroMab N86/8 dilution
1:2,000), anti-APT1 (Abcam ab91606 dilution 1:1,000), anti-GluA1
(Millipore AB1504 dilution 1:1,000). Secondary antibodies conju-
gated to HRP were from GE Healthcare and used at 1:10,000 dilu-
tions for 45 min at RT. For densitometry, Western blot films were
scanned and analysed in ImageJ followed by the appropriate statisti-
cal analysis. The integrated densities of bands of interest were
normalised to appropriate loading controls from the same gel. For
pull-downs and co-IPs, bound proteins were normalised to their
respective inputs. For GFP-trap experiments, bound proteins were
normalised to the GFP-Ago2 signal detected by anti-GFP in the pull-
down. All error bars on graphs represent standard error of the
mean.
Luciferase assays
DIV12 cortical cultures were co-transfected with the appropriate
luciferase constructs and FUGW-GFP vectors. Dual-luciferase
reporter assay system (Promega) was used to perform the assays
according to the manufacturer’s instructions. Values were normal-
ised for each of at least three independent experiments, and the
appropriate statistical analysis was performed. All error bars on
graphs represent standard error of the mean.
Puro-PLA assays
Cortical neurons were treated with 1uM puromycin during bath
application in the presence or absence of 50 lM NMDA plus 20 lM
glycine in HBS for 3 min at 37°C. Post-stimulation, cells were incu-
bated in conditioned media supplemented with 1 lM puromycin for
40 min. Neurons were then fixed in 4% paraformaldehyde, 2%
sucrose at RT for 10 min. Puro-PLA was performed using the
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Duolink in situ red PLA mouse/rabbit kit (Sigma) according to the
manufacturers’ protocol. Anti-puromycin (Millipore clone 12D10)
and anti-LIMK1 (Cell Signaling 3842) were used at 1:100 dilution.
Images were acquired as described above. The number of PLA-
positive particles/100 l of dendrite was quantified as shown in the
figures.
Surface labelling
Cells grown on coverslips were live labelled with anti-GluA2 (Milli-
pore MAB397) diluted 1:30 in HBS for 15 min at RT. Cells were
washed three times in HBS and fixed immediately in 4%
paraformaldehyde, 2% sucrose at RT for 10 min. Next, the cells
were blocked in 3% BSA for 1 h at RT followed by incubation with
the appropriate secondary antibody before being mounted. Images
were acquired from the coverslips and analysed as described above.
Organotypic hippocampal slice preparation and
biolistic transfection
Organotypic slices were prepared as described previously (Rocca
et al, 2013). In brief, P7 Wistar rats were sacrificed by cervical dislo-
cation, and the brains were removed and placed in ice-cold cutting
solution comprised of 238 mM Sucrose, 2.5 mM KCl, 26 mM
NaHCO3, 1 mM NaH2PO4, 5 mM MgCl2, 11 mM D-glucose and
1 mM CaCl2. Transverse hippocampal slices (350 lm) were cut
using a Leica VT122 S vibratome, washed three times in culture
media and plated on Millicell culture plate inserts (Millipore Corpo-
ration, Bedford, MA, USA) in 6-well plates containing culture
medium. Culture medium comprised 78.8% minimum essential
medium, 20% heat-inactivated horse serum, 30 mM HEPES, 16 mM
D-glucose, 5 mM NaHCO3, 1 mM CaCl2, 2 mM MgSO4, 68 lM
ascorbic acid, 1 lg/ml insulin, pH adjusted to 7.3 and 320–
330 mOsm. The slices were then cultured in an incubator (35°C, 5%
CO2) for 6–11 days in vitro (DIV) before biolistic transfection with
gene gun bullets prepared as described previously (O’Brien &
Lummis, 2006). Electrophysiological recordings were made from
slices from 2 to 5 days post-transfection.
Electrophysiology
Whole-cell patch-clamp electrophysiology experiments were
performed on transfected cells, visualised using fluorescence
microscopy, and in some cases neighbouring untransfected cells.
Recordings were performed in ACSF comprised of 119 mM NaCl,
2.5 mM KCl, 26 mM NaHCO3, 1 mM NaH2PO4, 4 mM CaCl2, 4 mM
MgCl2, 11 mM D-glucose, 0.05 mM picrotoxin and 0.001–0.01 mM
2-chloroadenosine (bubbled with 95% O2/5% CO2). Stimulating
electrodes were placed in the Schaffer collateral pathway, and pyra-
midal neurons in area CA1 were voltage-clamped at 60 mV using
pipettes with resistance 3–4 MΩs fabricated using a Sutter P-97
micropipette puller (Sutter Instruments, CA, USA). Pipettes
contained solution comprised of 130 mM CsMeSO4, 8 mM NaCl,
4 mM Mg-ATP, 0.3 mM Na-GTP, 0.5 mM EGTA, 10 mM HEPES,
6 mM QX-314 (pH 7.25, 290 mOsm). Recordings were made using
an Axon Instruments Multiclamp 700A or 700B (Molecular Devices,
Berkshire, UK). Excitatory post-synaptic currents (EPSC) amplitude,
series resistance, input resistance and DC were monitored and
analysed online and offline using the WinLTP software (Anderson &
Collingridge, 2007). Only cells with series resistance < 30 MΩ with
a change in series resistance < 20% from the start were included in
this study. Statistical significance was tested using a one-way
ANOVA followed by a post hoc Bonferroni’s multiple comparison
test in SigmaPlot 13 (Systat Software Inc., San Jose, CA, USA).
Expanded View for this article is available online.
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